The move to buy Loxo Oncology is the second multibillion-dollar cancer deal of the year by a major US pharma giant
Earnings report is the first under CEO Dave Ricks
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices